Literature DB >> 2448264

Immunogenicity of the gene S and Pre-S domains in hepatitis B virions and HBsAg filaments.

K H Heermann1, F Kruse, M Seifer, W H Gerlich.   

Abstract

The three morphological forms (20-nm particles, filaments, virions) of hepatitis B surface antigen (HBsAg) were isolated from serum of chronic virus carriers or from transfected cell lines. BALB/c mice and guinea pigs were immunized with the antigens and the antibody responses against the three antigenic domains of the viral envelope were assayed. The proportion of pre-S1, pre-S2 and gene S antibodies was similar to the molar proportion of the domains in the immunogens. The major gene S and pre-S1 epitopes were conformational, and the major epitopes of the pre-S2 domain were sequential. The immunogenicity of natural and recombinant antigens was identical. The proportion of subtype-specific antibodies was high. The results suggest that recombinant HBsAg filaments containing both subtypes ad and ay may be optimal hepatitis B vaccines.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2448264     DOI: 10.1159/000149993

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  19 in total

Review 1.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

Review 2.  Nature and display of hepatitis B virus envelope proteins and the humoral immune response.

Authors:  A Alberti; W H Gerlich; K H Heermann; P Pontisso
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Identification of the immunogenic domains in HBsAg preS1 region using overlapping preS1 fragment fusion proteins.

Authors:  Wei-Guo Hu; Jun Wei; Heng-Chuan Xia; Xin-Xiu Yang; Feng Li; Guang-Di Li; Yuan Wang; Zu-Chuan Zhang
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

4.  Hepatitis B virus large and middle glycoproteins are degraded by a proteasome pathway in glucosidase-inhibited cells but not in cells with functional glucosidase enzyme.

Authors:  Ender Simsek; Anand Mehta; Tianlun Zhou; Raymond A Dwek; Timothy Block
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 5.  Molecular biology of the hepatitis B virus for clinicians.

Authors:  Sibnarayan Datta; Soumya Chatterjee; Vijay Veer; Runu Chakravarty
Journal:  J Clin Exp Hepatol       Date:  2012-10-18

6.  Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein.

Authors:  Philippe Gripon; Isabelle Cannie; Stephan Urban
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein.

Authors:  V Lambert; D Fernholz; R Sprengel; I Fourel; G Deléage; G Wildner; C Peyret; C Trépo; L Cova; H Will
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

8.  Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line.

Authors:  X Lu; T M Block; W H Gerlich
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Correlation of preS antigens and clinical status during chronic hepatitis B virus infection.

Authors:  G Taliani; M Rapicetta; D Francisci; J Xiang; B Sarrecchia; C De Bac; G Stagni
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

10.  Synthesis and immunogenicity of hepatitis B virus envelope antigen expressed by recombinant vaccinia virus. Finding of retention signal in the C-terminal portion of the preS1 domain of subtype adyw.

Authors:  S Nĕmecková; L Kutinová; E Hamsíková; D Kunke; M Press; H Závadová; J Smrt; V Vonka
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.